Dexcom Q1 FY25: where the revenue came from and where it went
The whole income statement of Dexcom for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2025
- Reported
- May 1, 2025
Revenue$1.04B
+12% year over year
Gross profit$0.59B
57% margin
Operating profit$0.13B
13% margin
Net profit$0.11B
10% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.04 | 100% | +12% |
| US | 0.75 | 72% | +15% |
| Non US | 0.29 | 28% | +7% |
| Cost of revenue | −0.45 | 43% | |
| Gross profit | 0.59 | 57% margin | −4pp |
| R&D | −0.15 | 14% | −1pp |
| SG&A | −0.31 | 30% | −5pp |
| Operating profit | 0.13 | 13% margin | +2pp |
| Other income, net | 0.02 | ||
| Tax | −0.05 | ||
| Net profit | 0.11 | 10% margin | −6pp |
224 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest